EMA 25th anniversary virtual symposium: New approaches in patient-focused cancer drug development on 29 October 2020

We would like to inform you that the European Medicines Agency is hosting a symposium to explore themes such as the natural evolution of patients’ role from interested stakeholders to advisors and decision makers, evidence-based methods of patient preference data collection. In addition, topics, such as collaborative research networks and registries for real-world data generation, also in difficult areas, including rare cancers and palliative care, will be discussed.

The Agency shares the European Commission priorities of improving cancer prevention and care, and fully appreciates the opportunities brought by the rapid scientific and technological advances but also the challenges that these will bring.

Coupled with the digital transformation that features in many Commission policy areas, such as big data and digital platforms, there is a real opportunity to develop the impactful actions in the area of health data to speed up development and optimisation of cancer treatments while at the same time augmenting data generation to satisfy the evidentiary standards of patients, clinicians, regulators and payers.

Please click on the agenda for more details.

No registration is required to participate in this event . A link to the live broadcast will be available here during the event.

Should you have any questions on the content of the event, please contact us via: OncologySymposium2020@ema.europa.eu.

1 Like